Natural killer (NK) cells represent a heterogeneous population of innate lymphocytes with phenotypically and functionally distinct subsets. In particular, recent studies have identified a unique subset of NK cells residing within the liver that are maintained as tissue-resident cells, confer antigen-specific memory responses and exhibit different phenotypical and developmental characteristics compared with conventional NK (cNK) cells. These findings have encouraged researchers to uncover tissue-resident NK cells at other sites, and detailed analyses have revealed that these tissue-resident NK cells share many similarities with liver-resident NK cells and tissue-resident memory T cells. Here, we present a brief historical perspective on the discovery of liver-resident NK cells and discuss their relationship to cNK cells and other emerging NK cell subsets and their potential functions.
INTRODUCTION
NK cells are an important member of the innate immune system, playing crucial roles in host defense against microbial infections and developing tumors. 1,2 Unlike T cells and B cells, NK cells can be rapidly activated to exert natural cytotoxicity against target cells without the necessity of priming, and this process is delicately controlled by multiple activating and inhibitory surface receptors. 3 Additionally, NK cells also secrete an array of cytokines, among which IFNγ is mainly produced by NK cells during various physiological and pathological conditions. 1, 4 By producing cytokines or direct cytotoxicity to immune cells, NK cells are emerging as important regulators of adaptive immune responses. [4] [5] [6] NK cells are widely distributed throughout the body, including in lymphoid and non-lymphoid tissues. However, most of our knowledge concerning NK cells has been derived from studies performed on mouse splenic and human peripheral blood NK cells because of their ease of access. 7 These NK cells, now referred to as conventional NK (cNK) cells, originate in the bone marrow and move through the circulation to different tissues and organs. 7, 8 For decades, cNK cells were the only known innate lymphoid cells (ILCs). However, recent research into peripheral non-lymphoid tissues led to the discovery of diverse ILC subsets, which greatly expanded the knowledge of innate immunity and redefined our classic maps of the immune system. 9 Over recent years, NK-cell heterogeneity has also been appreciated, and tissue-resident NK cells have come into the spotlight. 8, 10, 11 In particular, we and others have recently found that the mutually exclusive expression of CD49a and DX5 could divide mouse liver NK cells into two distinct subsets. The CD49a − DX5 + subset resembles splenic NK cells and circulates in the blood; thus, they are called cNK cells. Another subset, liver-resident NK cells, selectively resides in the liver sinusoids and is characterized by the CD49a + DX5 − phenotype. 12, 13 These findings have encouraged the scanning of tissue-resident NK cells across the body, and tissue-resident NK cells in various tissues, such as the skin, uterus, salivary gland and adipose, have been successively discovered. [13] [14] [15] FINDING LIVER-RESIDENT NK CELLS Early recognition of liver NK-cell heterogeneity Previous studies have revealed that the liver contains a high frequency of NK cells relative to the spleen, peripheral blood and bone marrow and liver NK cells are phenotypically different from those in other tissues. 16 In adult mice, liver NK cells highly express tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but express low levels of markers associated with NK cell maturation, such as DX5, CD11b and Ly49 receptors. [17] [18] [19] By contrast, splenic NK cells are predominantly mature in phenotype. In early life, TRAIL + DX5 − CD11b lo phenotypically immature NK cells are predominant in the liver and abundant in the spleen. 18 However, the numbers of these NK cells in the spleen sharply decline after birth, but only mildly decrease in the liver with age and these NK cells maintain a stable subpopulation in the adult murine liver. 18 Consistent with these findings observed in mice, human liver NK cells also display unique features compared with their blood counterparts. For example, liver CD56 + CD3 − NK cells express relatively low levels of CD16, CD62L and inhibitory killer Ig-like receptors (KIRs) and high levels of CD69; moreover, human liver NK cells have weaker cytotoxic functions than blood NK cells. 20 Overall, the early studies of liver NK cells in mice and humans provided evidence of heterogeneity among NK cells but not lineage divergence.
Discovery of liver-resident NK cells
On the basis of earlier findings, we further researched the transcriptional, phenotypic and functional features of liver NK cells. Compared with NK cells in the bone marrow, peripheral blood and spleen, hepatic lymphocytes were enriched in DX5 − NK cells, which accounted for approximately half of hepatic NK cells, but were rare in other examined tissues. 12 Liver DX5 + NK cells were phenotypically similar to their splenic counterparts but distinct from liver DX5 − NK cells. 12 Genomic analysis further revealed that substantial differentially expressed genes existed between liver DX5 − and DX5 + NK cells, including those encoding inhibitory and activating receptors, cytokines, homing molecules, cytotoxic effectors and transcription factors. 12 Importantly, we found that liver DX5 − NK cells selectively expressed CD49a, which is rarely expressed by liver DX5 + NK cells, and thus it was considered to be a specific marker for liver DX5 − NK cells. 12, 13 DX5 − NK cells were previously regarded as an immature stage of cNK-cell development. 17, 21 Through adoptive transfer experiments, however, we found that CD49a + DX5 − NK cells from donor livers could not give rise to DX5 + NK cells and preferentially trafficked to the recipient liver after transfer, whereas donor CD49a − DX5 + NK cells exhibited nondiscriminatory migration between different tissues. 12 These findings suggest that CD49a + DX5 − NK cells are not developmental intermediates but represent a stable population.
Of particular interest, when we analyzed the phenotype of NK cells in the blood flow from different vessels, we observed that neither afferent nor efferent blood of the liver contained CD49a + DX5 − NK cells, which were instead present in the liver sinusoid blood. 7, 12 By contrast, CD49a − DX5 + NK cells were found in all blood sources. 7, 12 Parabiosis experiments between CD45.1 + and CD45.2 + mice showed that liver CD49a − DX5 + NK cells were confined to the host origin, whereas CD49a − DX5 + NK cells in the spleen and liver were derived from both the host and the other parabiont. 12, 13 Taking into account the above findings, liver CD49a + DX5 − NK cells were also called liver-resident NK cells, and CD49a − DX5 + NK cells represent circulating cNK cells.
Efforts have recently been made to explore whether human liver contains liver-resident NK cells. Hudspeth et al. found that compared with peripheral blood, the liver tissue and liver perfusates from healthy humans contained significantly higher percentages of CD56 bright NK cells that expressed high levels of CD69 and CXCR6 and low levels of CD62L, akin to murine liver-resident NK cells. 22 Furthermore, a proportion of human liver CD56 bright NK cells expressed CD49a, and these CD49a + NK cells were T-bet + Eomes − , 23 which is consistent with the transcription factor expression pattern found in murine liver CD49a + NK cells. However, CD49a + CD56 bright NK cells were present at a very low frequency (an average of 2.3%) and only identified in 12 of 29 livers examined. 23 More recently, it has been revealed that CXCR6 + or CD49e − NK cells are highly enriched in the human liver but are rare in the circulation, [24] [25] [26] suggesting that CXCR6 and CD49e might be potential markers identifying human liver-resident NK cells. However, unlike murine liver-resident NK cells, human liver CXCR6 + or CD49e − NK cells lacked T-bet expression and highly expressed Eomes (Table 1) . [24] [25] [26] 29 Development of liver-resident NK cells Liver-resident NK cells exhibit fundamentally different profiles and requirements of transcription factors compared with cNK cells. 30 For example, Hobit expression is low in cNK cells but specifically upregulated in liver-resident NK cells. 31 Hobit deficiency results in a sharp reduction in the number of liver-resident NK cells but has little impact on cNK cells. 31 Similarly, the T-box transcription factor T-bet is also strictly required for liver-resident NK cell development, while cNK cells are only moderately affected by the loss of T-bet. 13, 27 By contrast, Eomes is highly expressed in cNK cells compared with liver-resident NK cells, and in Eomes-deficient mice, a complete loss of cNK cells was observed, while liver-resident NK cells were not affected. 32 Acting upstream of Eomes, NFIL3 also exerts a more profound effect on cNK cells than on liverresident NK cells. 33 Recent studies have identified common progenitors that are committed to diverse innate lymphoid cell (ILC) lineages. Both the α-lymphoid progenitors (αLPs), which differ from common lymphoid progenitors (CLPs) by their expression of α4β7 and CXCR6, and early innate lymphoid progenitor (EILPs) expressing TCF1 can give rise to all known ILCs, including cNK cells and liver-resident NK cells, but lack T-and B-lymphocyte potential. 34, 35 Interestingly, multipotent progenitors that lose cNK-cell developmental potential but that can generate tissue-resident NK cells and other ILCs have been found, 36, 37 suggesting that liver-resident NK cells are developmentally separate from cNK cells. Additionally, sharing many similarities with mucosal ILC1s in terms of their development pathway, liver-resident NK cells have also been categorized as ILC1s, regardless of their cytotoxic capacity.
Common features of tissue-resident lymphocytes
In addition to the liver, other non-lymphoid tissues have also been found to contain tissue-resident NK cells, which share many common features with liver-resident NK cells. 38 The expression of CD49a and DX5 has been described as mutually exclusive to cNK cells and tissue-resident NK cells in the uterus, skin, kidney and liver. 13, 39 CD49a + DX5 − tissue-resident NK cells in the skin are T-bet-dependent and lack the expression of Eomes, like those found in the liver. 13 By contrast, neither uterus-resident NK cells, which express high levels of Eomes, nor kidney-resident NK cells rely on T-bet for their development. 13, 39, 40 CD49a is also a marker of the tissueresident NK-cell subset residing in the salivary gland, but these cells are mostly DX5-positive and dependent on TGF-β signaling for their development. 14 In addition to CD49a, CD69 is another tissue-resident marker, as shown by its constantly high expression among these NK cells. 38 The concept of tissue residency has also been used to describe adaptive lymphocytes, which has been mostly driven by studies on CD8 + memory T cells. 41 Tissue-resident memory T (Trm) cells share many markers with tissue-resident NK cells, including the high expression of CD49a and CD69 and low amounts of CD62L and S1PR1. 42 Moreover, a recent study has found that the transcription factor Hobit is specifically upregulated in tissue-resident lymphocytes, including Trm cells, liver-resident NK cells and NKT cells. 31 Hobit and Blimp1 cooperate to specifically promote Trm-and NKT-cell development, while liver-resident NK cells are specifically dependent on Hobit. 31 Further analysis revealed that Hobit and Blimp1 repressed a series of genes associated with tissue egress, including S1pr1, Ccr7 and Klf2, implicating a universal program of tissue residency shared by diverse tissue-resident lymphocyte populations. 31, 43 POTENTIAL FUNCTIONS OF LIVER-RESIDENT NK CELLS NK cells have long been considered short-lived, non-antigenspecific effectors of innate immunity. However, several lines of evidence have unveiled that NK cells can mount antigenspecific secondary responses that resemble classical immunological memory. 44 The first evidence for specific NK-cell responses to antigens was observed in a mouse model of contact hypersensitivity (CHS). 45 Von Andrian and colleagues found that Rag2 −/− and SCID mice, which lack T and B cells but possess NK cells, mediated CHS responses in a haptenspecific manner, while Rag2 −/− x Il2rg − / mice, which lack T, B, and NK cells, did not. 45 In particular, only NK cells that are localized in the livers, and not those in the spleens, mediate memory responses upon sensitization with haptens or viruslike particles. 28, 45 Moreover, memory responses mediated by hepatic NK cells are dependent on CXCR6, 28 a chemokine receptor that is highly expressed by CD49a + DX5 − liver-resident NK cells. 12 Enlightened by these findings, we adoptively transferred liver-resident NK cells or cNK cells from haptensensitized mice to naïve mice and found that the recipients of sensitized liver-resident NK cells, but not cNK cells, displayed vigorous CHS responses after challenge. 12 In addition, our recent study indicated that the adoptive transfer of liver CD49a + DX5 − NK cells from influenza virus-infected mice into naive mice conferred protective immunity against secondary influenza virus infection, while transferred lung NK cells did not. 46 These studies suggest that NK cells mediating antigenspecific responses are confined to liver CD49a + DX5 − NK cells but the tissue residency of this subset makes migration events during NK-cell-mediated memory responses more complicated than expected. It has previously been hypothesized that naive NK cells traffic to draining lymph nodes where they are primed by antigen-presenting cells upon sensitization, then, they migrate to the liver where they persist as long-lived memory cells, and finally emigrate into the effector site to evoke CHS upon re-challenge. 47 This model is largely based on memory T-cell theory. Direct evidence of each event is still lacking, and the mechanism underlying how tissue-resident NK cells exit from their initial place to other sites remains mysterious.
As an immune tolerant organ, the liver is predisposed to chronic infections and tumorigenesis, and the crosstalk between liver-resident antigen-presenting cells and circulating lymphocytes has been implicated in this process. [48] [49] [50] [51] To date, however, little is known about the role of liver-resident NK cells in liver tolerance and diseases, as most previous studies have utilized bulk liver NK cells as research subjects. These studies have indicated that hepatic NK cells may play dual roles, protective or pathogenic, in different disease settings. 48, 52 Accumulating evidence suggests that in the pathogenesis of various liver diseases, such as acute viral hepatitis and liver fibrosis, NK cells could accumulate in the liver and display enhanced reactivity, [53] [54] [55] [56] which can be beneficial in inhibiting viral infection and tumor development, but which may also induce hepatocellular damage and inhibit liver regeneration. 52 In certain liver diseases, such as chronic hepatitis B virus (HBV) infection and tumor, the impairment of NK cell 
